S
Silgan Holdings Inc.
SLGN · Consumer Cyclical
Q4 FY2025
Earning ended Dec 31, 2025Report generated Mar 10, 2026
The Closures Compounder Nobody Notices Inside a Metal Can
The market prices Silgan as a leveraged bet on canned soup — a mature, slow-decay business deserving a discount multiple. What it misses is that the Dispensing and Specialty Closures segment has quietly crossed the halfway mark of adjusted EBITDA, and that business carries engineering switching costs, equipment co-dependency, and exposure to beauty and healthcare growth that structurally deserves a meaningfully higher multiple than steel cans. The entire company is being priced on the anchor; the compounder rides along for free.
Flowly Score
Apr 16 Close
+255%$40.81
Fair Value
$145.00
56
Averageat $40.81
Business Strength6/10
The moat is real but split between two fundamentally different businesses — the closures segment earns genuine switching costs through co-manufactured equipment dependencies, while the metal containers anchor faces slow, structural erosion from flexible packaging that no amount of operational excellence reverses. Management has executed a credible mix-shift strategy, but the business is still more hardware store than precision instruments shop.
Financial Resilience5/10
Operating cash flow consistently towers above reported earnings — a textbook signal of real economic profit — but the balance sheet carries private-equity-level leverage that transforms an ordinary volume soften into a financial stress event; the Altman Z-Score at distress levels isn't decorative.
Growth & Trajectory5/10
Revenue swings are mostly commodity pass-through noise rather than volume signal, masking what is actually a quiet but credible mix shift — the closures segment crossing the majority of adjusted EBITDA is a structural inflection, not a headline number. Flat EPS guidance for 2026 despite higher operating income captures the leverage tax on any growth this business earns.
Valuation8/10at $44.18
Every framework — FCF yield near double digits, EV/EBITDA below the five-year range, and DCF outputs well above current price even under pessimistic assumptions — points to a business that the market is pricing on its worst fears rather than its normalized earnings power. The discount is real but appears excessive relative to the durability of cash generation.
Risk4/10
The risk matrix is genuinely crowded: substantial leverage amplifying any volume shock, flexible packaging slowly dissolving the foundation of the metal containers business, a major customer bankruptcy demonstrating concentration fragility, and tariff exposure on primary inputs — individually manageable, collectively a portfolio of compounding vulnerabilities that earns a below-average score.
The investment case rests on a valuation gap that is difficult to rationalize even under genuinely conservative assumptions. The business generates consistently strong free cash flow — structurally understated by heavy amortization from serial acquisitions — and has been quietly transforming its earnings mix toward a higher-quality segment without blowing up the balance sheet in the process. At the current multiple, you are paying less for this enterprise than at almost any point in the past five years, while the underlying earnings mix is objectively better today than it was then. Cheaper multiple, better mix — that combination is not common. The trajectory toward the closures business becoming the defining driver is unmistakable. Pet food holding metal containers volumes stable in the near term buys the strategic clock time it needs, while the healthcare dispensing target represents genuine organic compounding — not acquisition-dependent. The Vayner integration delivering synergies beyond initial targets suggests that despite the debt-heavy acquisition strategy, the deals have been creating rather than destroying value, which is a higher bar than most packaging roll-ups clear. The single specific risk that prevents this from being a high-conviction call is the leverage profile magnifying what could otherwise be recoverable volume shocks. The major customer bankruptcy is the warning shot — concentration in a slowly declining category, financed with a balance sheet that absorbs surprises poorly. If flexible packaging substitution accelerates beyond its current gradual pace and large CPG companies make decisive format decisions, the operating leverage embedded in a high fixed-cost manufacturing network turns sharply negative, and the Z-Score concern stops being theoretical.